PubMed Europe PMC Scholia Long-term clinical outcome in patients with glutathione synthetase deficiency
The SELECT trial is a major breakthrough, says Yale Medicine cardiologist Harlan Krumholz, MD, SM, explaining that while semaglutide [given as Ozempic] was already known to lower the risk of heart disease in people with diabetes, the SELECT trial was the first to show that Wegovy, which contains a higher dose of semaglutide, also lowers that risk even in people who dont have diabetes
Its antioxidant action also slows signs of aging by protecting against cellular damage and supporting detox
When glutathione is present at optimal levels, it scavenges oxidants and acts as an anti-inflammatory, which is helpful in the elderly
GLP-1 friendly meals for specific situations Injection day meals Many users notice stronger appetite suppression and more GI sensitivity on injection day and the day after